Strategic Wealth Partners Ltd. Increases Stock Position in CVS Health Co. (NYSE:CVS)

Strategic Wealth Partners Ltd. raised its stake in shares of CVS Health Co. (NYSE:CVSGet Rating) by 12.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,553 shares of the pharmacy operator’s stock after purchasing an additional 1,926 shares during the period. Strategic Wealth Partners Ltd.’s holdings in CVS Health were worth $1,777,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Orion Portfolio Solutions LLC lifted its holdings in CVS Health by 18.1% during the first quarter. Orion Portfolio Solutions LLC now owns 14,912 shares of the pharmacy operator’s stock valued at $1,509,000 after purchasing an additional 2,286 shares in the last quarter. Baader Bank INC lifted its holdings in CVS Health by 0.5% during the first quarter. Baader Bank INC now owns 109,641 shares of the pharmacy operator’s stock valued at $11,097,000 after purchasing an additional 500 shares in the last quarter. Wealthfront Advisers LLC lifted its holdings in CVS Health by 13.2% during the first quarter. Wealthfront Advisers LLC now owns 87,610 shares of the pharmacy operator’s stock valued at $8,867,000 after purchasing an additional 10,220 shares in the last quarter. Weiss Multi Strategy Advisers LLC lifted its holdings in CVS Health by 311.7% during the first quarter. Weiss Multi Strategy Advisers LLC now owns 58,170 shares of the pharmacy operator’s stock valued at $5,887,000 after purchasing an additional 44,041 shares in the last quarter. Finally, Continuum Advisory LLC purchased a new position in CVS Health during the first quarter valued at $687,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 0.6 %

NYSE CVS opened at $101.05 on Thursday. The firm has a 50 day simple moving average of $99.11 and a 200-day simple moving average of $99.39. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.65 and a current ratio of 0.91. CVS Health Co. has a one year low of $81.78 and a one year high of $111.25. The firm has a market cap of $132.66 billion, a price-to-earnings ratio of 16.33, a PEG ratio of 1.55 and a beta of 0.73.

CVS Health (NYSE:CVSGet Rating) last posted its quarterly earnings data on Wednesday, August 3rd. The pharmacy operator reported $2.40 EPS for the quarter, beating the consensus estimate of $2.16 by $0.24. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. The business had revenue of $80.64 billion during the quarter, compared to analyst estimates of $76.38 billion. During the same quarter last year, the firm posted $2.42 earnings per share. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Co. will post 8.54 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 1st. Investors of record on Friday, July 22nd were paid a $0.55 dividend. The ex-dividend date was Thursday, July 21st. This represents a $2.20 dividend on an annualized basis and a yield of 2.18%. CVS Health’s dividend payout ratio is currently 35.77%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CVS. Loop Capital began coverage on shares of CVS Health in a research note on Thursday, June 16th. They issued a “buy” rating and a $120.00 price target on the stock. UBS Group raised their price target on shares of CVS Health from $118.00 to $127.00 and gave the stock a “buy” rating in a research note on Thursday, August 4th. Mizuho raised their price target on shares of CVS Health from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Monday, August 15th. Sanford C. Bernstein downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $122.00 to $112.00 in a research note on Thursday, May 26th. Finally, Evercore ISI raised their price target on shares of CVS Health from $120.00 to $125.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 7th. Four research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $117.59.

Insider Buying and Selling

In related news, EVP Thomas M. Moriarty sold 138,654 shares of CVS Health stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total value of $13,172,130.00. Following the completion of the transaction, the executive vice president now owns 626,273 shares in the company, valued at $59,495,935. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Thomas M. Moriarty sold 138,654 shares of the business’s stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total transaction of $13,172,130.00. Following the completion of the sale, the executive vice president now owns 626,273 shares in the company, valued at approximately $59,495,935. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Alan Lotvin sold 22,541 shares of CVS Health stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now directly owns 109,183 shares in the company, valued at $11,355,032. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.